申请人:Heumann Pharma GmbH & Co.
公开号:US05254583A1
公开(公告)日:1993-10-19
New salts of 2-(2,6-dichloroanilino)-phenylacetic acid corresponding to the general formula (I) ##STR1## in which Me stands for a rubidium or caesium atom, a process for the preparation of these salts and pharmaceutical preparations containing these salts are described. The new salts and pharmaceutical preparations containing the salts can be used successfully for the treatment of inflammatory and rheumatic processes and painful conditions.
描述了符合一般公式(I)的2-(2,6-二氯苯胺基)-苯乙酸的新盐,其中Me代表铷或铯原子,描述了制备这些盐的过程以及含有这些盐的药物制剂。这些新盐和含有这些盐的药物制剂可成功用于治疗炎症和风湿病过程以及疼痛症状。